Issue 35, 2015

Radioactive lutetium metallofullerene 177LuxLu(3−x)N@C80–PCBPEG derivative: a potential tumor-targeted theranostic agent

Abstract

A radioactive metallofullerene 177LuxLu(3−x)N@C80 was firstly synthesized by means of neutron irradiation on Lu3N@C80. After modification by methoxypolyethylene glycol amine, in vivo investigation on tumor-bearing mice was performed. The results reveal favorable affinity toward tumors, suggesting that the obtained 177LuxLu(3−x)N@C80–PCBPEG could be promising for tumor diagnosis and therapy.

Graphical abstract: Radioactive lutetium metallofullerene 177LuxLu(3−x)N@C80–PCBPEG derivative: a potential tumor-targeted theranostic agent

Supplementary files

Article information

Article type
Communication
Submitted
22 May 2015
Accepted
01 Aug 2015
First published
07 Aug 2015

J. Mater. Chem. B, 2015,3, 7011-7013

Author version available

Radioactive lutetium metallofullerene 177LuxLu(3−x)N@C80–PCBPEG derivative: a potential tumor-targeted theranostic agent

G. Zhang, Z. Sun, H. Song, M. Zhen, M. Guan, T. Chu, S. Luo, C. Wang and C. Shu, J. Mater. Chem. B, 2015, 3, 7011 DOI: 10.1039/C5TB00983A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements